Topics

Research

We can stop COVID-19: Moderna vaccine success gives world more hope

We can stop COVID-19: Moderna vaccine success gives world more hope

By: Julie Steenhuysen, Michael Erman
Source: Reuters
Date of Publication: November 16th, 2020
Moderna Inc's MRNA.O experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations.
How two companies sprinted ahead in extraordinary race for a COVID vaccine

How two companies sprinted ahead in extraordinary race for a COVID vaccine

By: Michael Erman, Julie Steenhuysen
Source: Reuters
Date of Publication: November 17th, 2020
Just as the novel coronavirus was gaining a foothold in the United States in mid-March, Pfizer Inc Chief Executive Albert Bourla called on his top vaccine scientists and laid out a clear mission: “He basically said, ‘Your mandate is to get this vaccine made. And if you need resources, you come and you ask for them, and you’re going to get them’,”chief viral vaccine scientist Philip Dormitzer told Reuters.
BioNTech hopes COVID-19 vaccine will immunize for at least a year

BioNTech hopes COVID-19 vaccine will immunize for at least a year

By: Ludwig Burger, Patricia Weiss
Source: Reuters
Date of Publication: November 9th, 2020
BioNTech's BNTX.O co-founder and chief executive said he was optimistic that the protective effect of its experimental COVID-19 vaccine, co-developed with Pfizer PFE.N, would last for at least a year.
Instant view: Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effective

Instant view: Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effective

Source: Reuters
Date of Publication: November 9th, 2020
Pfizer Inc PFE.N said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.
Moderna loses challenge to Arbutus patent on vaccine technology

Moderna loses challenge to Arbutus patent on vaccine technology

By: Jan Wolfe
Source: Reuters
Date of Publication: July 23rd, 2020
Shares of Moderna Inc fell nearly 10% after it lost a bid to invalidate a U.S. patent owned by Arbutus Biopharma that poses a potential obstacle to Moderna’s efforts to develop next-generation vaccines, including a coronavirus vaccine.
Gilead’s next COVID-19 treatment advancement could keep patients out of hospitals

Gilead’s next COVID-19 treatment advancement could keep patients out of hospitals

By: Sy Mukherjee
Source: Fortune
Date of Publication: June 22nd, 2020
Gilead won the first Food and Drug Administration (FDA) emergency authorization for a COVID-19 treatment in May. Now, the biotech giant says, it will soon begin clinical trials for a different version of the same experimental drug, remdesivir, which might make it easier to administer outside of a hospital or ICU wing.
'Brands Are Really Going To Be Judged.' Companies Are Walking a Tightrope During the COVID-19 Pandemic

'Brands Are Really Going To Be Judged.' Companies Are Walking a Tightrope During the COVID-19 Pandemic

By: Katy Steinmetz
Source: Time Magazine
Date of Publication: April 2nd, 2020
Like just about everyone, Hotels.com had to change plans when the pandemic arrived.
J&J to begin human trials of COVID-19 vaccine in second half of July

J&J to begin human trials of COVID-19 vaccine in second half of July

By: Saumya Sibi Joseph
Source: Reuters
Date of Publication: June 10th, 2020
Johnson & Johnson said on Wednesday it would start human trials of its potential COVID-19 vaccine in the second half of July, two months earlier than planned, as drugmakers race to develop a shot for the deadly respiratory disease.
AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works

AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works

By: Matthew Herper
Source: Stat News
Date of Publication: June 4th, 2020
The drug giant AstraZeneca said Thursday that it has found partners to manufacture and distribute 2 billion doses of the experimental Covid-19 vaccine created by Oxford University, inking a series of deals with non-government organizations and another manufacturer.
A COVID-19 vaccine has passed its first human trial. But is it the frontrunner?

A COVID-19 vaccine has passed its first human trial. But is it the frontrunner?

By: Nsikan Akpan
Source: National Geographic
Date of Publication: May 29th, 2020
Moderna Therapeutics has just entered phase two of its clinical trials. Here's how mRNA vaccines work and what the latest developments mean.